These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


333 related items for PubMed ID: 10674681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
    Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, Raksapraidee R, Carrara VI, Bancone G, Watson J, Moore KA, Wiladphaingern J, Proux S, Sriprawat K, Winterberg M, Cheah PY, Chue AL, Tarning J, Imwong M, Nosten F, White NJ.
    Clin Infect Dis; 2018 Oct 30; 67(10):1543-1549. PubMed ID: 29889239
    [Abstract] [Full Text] [Related]

  • 9. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
    Kshirsagar NA, Gogtay NJ, Rajgor D, Dalvi SS, Wakde M.
    Ann Trop Med Parasitol; 2000 Mar 30; 94(2):189-90. PubMed ID: 10827874
    [No Abstract] [Full Text] [Related]

  • 10. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K, Durrani N, Rahim S, Rowland M.
    Trans R Soc Trop Med Hyg; 2007 Nov 30; 101(11):1081-7. PubMed ID: 17707447
    [Abstract] [Full Text] [Related]

  • 11. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
    Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalearmrult K, Mint HY, Maneekan P, White NJ, Gourdeuk VR, Brittenham GM, Looareesuwan S.
    Am J Trop Med Hyg; 2003 Jul 30; 69(1):14-8. PubMed ID: 12932090
    [Abstract] [Full Text] [Related]

  • 12. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
    Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, Setiabudy R, Nurleila S, Ekawati LL, Elyazar I, Farrar J, Sudoyo H, Baird JK.
    Antimicrob Agents Chemother; 2013 Mar 30; 57(3):1128-35. PubMed ID: 23254437
    [Abstract] [Full Text] [Related]

  • 13. Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.
    Hamid MMA, Thriemer K, Elobied ME, Mahgoub NS, Boshara SA, Elsafi HMH, Gumaa SA, Hamid T, Abdelbagi H, Basheir HM, Marfurt J, Chen I, Gosling R, Price RN, Ley B.
    Malar J; 2018 Mar 16; 17(1):117. PubMed ID: 29548285
    [Abstract] [Full Text] [Related]

  • 14. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria.
    von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G.
    Trop Med Int Health; 2001 Feb 16; 6(2):92-8. PubMed ID: 11251903
    [Abstract] [Full Text] [Related]

  • 15. Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial.
    Priotto G, Kabakyenga J, Pinoges L, Ruiz A, Eriksson T, Coussement F, Ngambe T, Taylor WR, Perea W, Guthmann JP, Olliaro P, Legros D.
    Trans R Soc Trop Med Hyg; 2003 Feb 16; 97(3):325-30. PubMed ID: 15228253
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
    von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, Coleman R, Ude JI, Sadiq A, Duraisingh M, Warhurst D, Alloueche A, Targett G, McAdam K, Greenwood B, Walraven G, Olliaro P, Doherty T.
    Lancet; 2000 Jan 29; 355(9201):352-7. PubMed ID: 10665554
    [Abstract] [Full Text] [Related]

  • 17. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
    Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkenberg E, Whitty CJ, Rowland M.
    JAMA; 2007 May 23; 297(20):2201-9. PubMed ID: 17519409
    [Abstract] [Full Text] [Related]

  • 18. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
    Fryauff DJ, Sumawinata I, Purnomo, Richie TL, Tjitra E, Bangs MJ, Kadir A, Ingkokusumo G.
    Am J Trop Med Hyg; 1999 Apr 23; 60(4):542-6. PubMed ID: 10348226
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
    Adam I, A-Elbasit IE, Idris SM, Malik EM, Elbashir MI.
    Ann Trop Med Parasitol; 2005 Jul 23; 99(5):449-55. PubMed ID: 16004704
    [Abstract] [Full Text] [Related]

  • 20. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ.
    Trop Med Int Health; 2004 Nov 23; 9(11):1184-90. PubMed ID: 15548314
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.